Related Experiment Video
Updated: Sep 12, 2025

Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
Shone's Syndrome and Transplant: A Road Less Traveled
Lyana Labrada1, Tripti Gupta2, Christiane Haeffele3
1Department of Cardiovascular Diseases, Temple University Hospital, Philadelphia, Pennsylvania, USA.
Insights
Shone's syndrome, a congenital heart defect, often requires advanced therapies like heart transplant. Early referral and multidisciplinary care are crucial for managing these complex cases.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Advanced Cardiac Therapies
Background:
- Shone's syndrome is a rare congenital heart disease characterized by four lesions causing left ventricular inflow and outflow obstruction.
- This condition leads to lifelong hemodynamic challenges, frequently necessitating advanced treatment modalities.
Observation:
- This case series examines eight patients with Shone's syndrome referred for advanced therapy evaluation.
- Six patients received heart transplants, while two underwent dual organ transplants.
- Two transplant recipients did not survive post-procedure.
Findings:
- Transplant decisions for Shone's syndrome involve complex considerations, including pulmonary hypertension and the need for single versus dual organ transplantation.
- Patients experienced intricate pre- and postoperative courses.
Implications:
- Early referral for advanced therapies is vital for patients with Shone's syndrome.
- Multidisciplinary evaluation and individualized care plans are essential for optimizing outcomes in this complex patient cohort.
Abstract:
"Shone's syndrome" was identified in 1963 as a constellation of 4 coexisting lesions leading to left ventricular inflow and outflow obstruction. This congenital heart disease syndrome has hemodynamic consequences throughout the lifetime of patients with this syndrome, and these patients often progress to requiring advanced therapies. This case series reviews the complex decision-making involved in advanced therapy evaluation for this specific patient population. We present 8 cases of patients with Shone's syndrome who were referred for advanced therapies. Of these patients, 6 patients went on to heart transplant alone and 2 patients underwent dual organ transplant. Two patients died after transplant. These cases each highlight important considerations for transplant in this patient population, including the development of pulmonary hypertension, potential need for single vs dual organ transplant, and complex pre- and postoperative courses. We emphasize the importance of early referral for advanced therapies, multidisciplinary evaluation, and individualized care for these complex patients.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cell-mediated Immune Responses
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

